Mangrove Partners Lantheus Holdings, Inc. Transaction History

Mangrove Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$78.23 - $110.01 $7.06 Million - $9.93 Million	-90,296 Reduced 51.53%	84,940 $8.29 Million
Q4 2024 Feb 14, 2025	SELL	$76.22 - $116.71 $1.48 Million - $2.27 Million	-19,471 Reduced 10.0%	175,236 $15.7 Million
Q3 2024 Nov 14, 2024	BUY	$77.7 - $123.62 $621,600 - $988,960	8,000 Added 4.28%	194,707 $21.4 Million
Q2 2024 Aug 14, 2024	BUY	$58.87 - $83.05 $755,831 - $1.07 Million	12,839 Added 7.38%	186,707 $15 Million
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $8.3 Million - $14.4 Million	173,868 New	173,868 $14.4 Million

478

68.9M

522K

312K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $3.64B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

Stay updated on Mangrove Partners with notifications on news.